Financial News
Alnylam Pharmaceuticals (NQ: ALNY )
235.18
-2.65
(-1.11%)
Streaming Delayed Price
Updated: 12:38 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Alnylam Pharmaceuticals
![](https://mms.businesswire.com/media/20230503005757/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230503005131/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Alnylam Issues 2022 Corporate Responsibility Report
May 03, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/04/27/dementia-3051832_1920.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart
April 11, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://mms.businesswire.com/media/20230426005802/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230424135734_why-legend-biotech-stock-is-having-its-best-month.jpg)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Alnylam Pharmaceuticals
March 21, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Alnylam Pharmaceuticals's Return On Capital Employed Insights
February 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Alnylam Pharmaceuticals
February 24, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](https://mms.businesswire.com/media/20230420005146/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](/next-assets/images/schema-image-default.png)
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/12/arwr.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/abus_1_0.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/04/medical-device-stocks-hospital-stocks-healthcare-stocks.jpg)
![](https://mms.businesswire.com/media/20230308005250/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_4014.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230301005134/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230223005143/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4643.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230221005335/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230202005129/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://www.valuewalk.com/wp-content/uploads/2022/09/Telehealth_1663693190-768x423.jpg)
Five Best And Worst Performing Healthcare Stocks In December 2022
January 22, 2023
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
January 18, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.